| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |